Should Watson Be Consulted for a Second Opinion
Bibliographic Data
| ID | 15745822 |
|---|---|
| Authors | David D Luxton (0000-0002-8234-0011, Behavioral Tech Research, Inc, corresponding author) |
| Year | 2019 |
| Volume | 21 |
| Issue | 2 |
| Pages | E131-137 |
| Publication date | 2019-02-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2019.131 |
| PMID | 30794122 |
| OpenAlex | W2916650597 |
| Language | EN |
| Citations received | 6 |
| References cited | 1 |
This article discusses ethical responsibility and legal liability issues regarding use of IBM Watson TM for clinical decision making. In a case, a patient presents with symptoms of leukemia. Benefits and limitations of using Watson or other intelligent clinical decision-making tools are considered, along with precautions that should be taken before consulting artificially intelligent systems. Guidance for health care professionals and organizations using artificially intelligent tools to diagnose and to develop treatment recommendations are also offered
Health care · Health professionals · IBM · Liability · Political science · Public relations · Watson · Artificial Intelligence in Healthcare and Education · Biomedical Text Mining and Ontologies · Computer Science · Electronic Health Records Systems · Law · Medicine · Psychology · Artificial Intelligence
| Citations per year | 0.86 |
|---|---|
| Citation span | 2019 - 2026 (8) |
| Highly cited | No |